tiprankstipranks
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market
ERNA
Eterna Therapeutics
RESEARCH TOOLSreports

Eterna Therapeutics (ERNA) Income Statement

309 Followers

Eterna Therapeutics Income Statement

Last quarter (Q1 2026), Eterna Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Eterna Therapeutics's net income was $-5.51M. See Eterna Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 582.00K$ 68.00K$ 0.00$ 0.00
Gross Profit
$ 0.00$ 486.00K$ -168.00K$ 0.00$ 0.00
Operating Expenses
$ 9.32M$ 16.16M$ 20.97M$ 33.22M$ 113.73M
Depreciation and Amortization
$ 263.00K$ 1.64M$ 1.12M$ 497.00K$ 459.00K
EBITDA
$ -13.84M$ -36.12M$ -19.93M$ -24.01M$ -121.95M
Operating Income
$ -9.32M$ -15.67M$ -21.14M$ -33.22M$ -113.73M
Other Income/Expenses
$ -4.81M$ -28.84M$ -536.00K$ 8.68M$ -8.75M
Pretax Income
$ -14.13M$ -44.51M$ -21.67M$ -24.53M$ -122.48M
Net Income
$ -14.08M$ -44.54M$ -21.67M$ -24.58M$ -122.55M
Per Share Metrics
Basic EPS
$ -56.00$ -39.25$ -102.00$ -201.50$ -1.42K
Diluted EPS
$ -56.00$ -39.25$ -102.00$ -201.50$ -1.42K
Weighted Average Shares Outstanding
 252.28K 1.14M 212.56K 122.04K 86.60K
Weighted Average Shares Outstanding (Diluted)
 252.28K 1.14M 212.56K 122.04K 86.60K
Currency in USD

Eterna Therapeutics Earnings and Revenue History